000			01975nam a2200409 i 4500
001			ocn959928473
003			OCoLC
005			20180119112548.0
006			m o d f
007			cr bn||||a||||
008			161005s2016 dcu ob f000 0 eng c
040			_aGPO _beng _erda _epn _cGPO _dOCLCO _dGPO
042			_apcc
043			_an-us---
050	1	4	_aKF27 _b.E5514 2016b
074			_a1019-C-01 (online)
086	0		_aY 4.C 73/8:114-142
088			_aSerial no. 114-142 (United States. Congress. House. Committee on Energy and Commerce)
099			_aY 4.C 73/8:114-142
110	1		_aUnited States. _bCongress. _bHouse. _bCommittee on Energy and Commerce. _bSubcommittee on Commerce, Manufacturing, and Trade, _eauthor.
245	1	4	_aThe pet medications industry : _bissues and perspectives : hearing before the Subcommittee on Commerce, Manufacturing, and Trade of the Committee on Energy and Commerce, House of Representatives, One Hundred Fourteenth Congress, second session, April 29, 2016.
264		1	_aWashington : _bU.S. Government Publishing Office, _c2016.
300			_a1 online resource (iii, 94 pages)
336			_atext _btxt _2rdacontent
337			_acomputer _bc _2rdamedia
338			_aonline resource _bcr _2rdacarrier
588			_aTitle from title screen (viewed on Oct. 5, 2016).
500			_aPaper version available for sale by the Superintendent of Documents, U.S. Government Publishing Office.
504			_aIncludes bibliographical references.
500			_a"Serial No. 114-142."
500			_aCRDP Project record.
650		0	_aPet medicine _zUnited States.
650		0	_aPets _xDiseases _xTreatment _zUnited States.
650		0	_aPet supplies industry _zUnited States.
655		7	_aLegislative hearings. _2lcgft
776	0	8	_iPrint version: _aUnited States. Congress. House. Committee on Energy and Commerce. Subcommittee on Commerce, Manufacturing, and Trade. _tPet medications industry _w(OCoLC)960372776
856	4	0	_uhttp://purl.fdlp.gov/GPO/gpo73139
999			_c268727 _d268727